- Home
- NAAS vs DRRX Comparison
NAAS vs DRRX Comparison
Compare NAAS & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAAS
- DRRX
- Stock Information
- Founded
- NAAS 2019
- DRRX 1998
- Country
- NAAS China
- DRRX United States
- Employees
- NAAS N/A
- DRRX N/A
- Industry
- NAAS Other Specialty Stores
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- NAAS Consumer Discretionary
- DRRX Health Care
- Exchange
- NAAS Nasdaq
- DRRX Nasdaq
- Market Cap
- NAAS 40.1M
- DRRX 44.4M
- IPO Year
- NAAS 2017
- DRRX 2000
- Fundamental
- Price
- NAAS $2.03
- DRRX $0.85
- Analyst Decision
- NAAS
- DRRX Buy
- Analyst Count
- NAAS 0
- DRRX 2
- Target Price
- NAAS N/A
- DRRX $5.00
- AVG Volume (30 Days)
- NAAS 186.3K
- DRRX 124.3K
- Earning Date
- NAAS 11-20-2024
- DRRX 11-13-2024
- Dividend Yield
- NAAS N/A
- DRRX N/A
- EPS Growth
- NAAS N/A
- DRRX N/A
- EPS
- NAAS N/A
- DRRX N/A
- Revenue
- NAAS $43,258,393.00
- DRRX $8,594,000.00
- Revenue This Year
- NAAS $19.53
- DRRX $54.32
- Revenue Next Year
- NAAS $151.36
- DRRX N/A
- P/E Ratio
- NAAS N/A
- DRRX N/A
- Revenue Growth
- NAAS 50.34
- DRRX N/A
- 52 Week Low
- NAAS $1.42
- DRRX $0.48
- 52 Week High
- NAAS $40.20
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- NAAS 31.54
- DRRX 42.97
- Support Level
- NAAS $1.98
- DRRX $0.72
- Resistance Level
- NAAS $2.16
- DRRX $0.83
- Average True Range (ATR)
- NAAS 0.22
- DRRX 0.08
- MACD
- NAAS -0.06
- DRRX 0.02
- Stochastic Oscillator
- NAAS 8.10
- DRRX 52.40
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .